- SGMO has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $13.9 million.
- SGMO has traded 64,995 shares today.
- SGMO is down 3.2% today.
- SGMO was up 5.6% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in SGMO with the Ticky from Trade-Ideas. See the FREE profile for SGMO NOW at Trade-Ideas More details on SGMO: Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of zinc finger DNA-binding proteins (ZFPs) for gene regulation and gene modification in the United States. Currently there are 4 analysts that rate Sangamo BioSciences a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Sangamo BioSciences has been 829,200 shares per day over the past 30 days. Sangamo BioSciences has a market cap of $773.7 million and is part of the health care sector and drugs industry. The stock has a beta of 1.35 and a short float of 17.1% with 8.04 days to cover. Shares are down 13.8% year-to-date as of the close of trading on Wednesday.